JOINN LABORATORIES(CHINA)CO.,LTD. Joinn Laboratories(China)Co.,Ltd. Share Price Hong Kong S.E.
Equities
6127
CNE100004BP3
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.47 HKD | +5.93% |
|
-4.25% | -26.36% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.35B 326M 2.55B 27.23B | Sales 2025 * | 2.8B 389M 3.04B 32.42B | Capitalization | 11.3B 1.57B 12.25B 131B |
|---|---|---|---|---|---|
| Net income 2024 * | 26M 3.6M 28.17M 301M | Net income 2025 * | 598M 82.91M 648M 6.92B | EV / Sales 2024 * | 3.41 x |
| Net cash position 2024 * | 3.26B 453M 3.54B 37.76B | Net cash position 2025 * | 3.59B 498M 3.89B 41.56B | EV / Sales 2025 * | 2.75 x |
| P/E ratio 2024 * |
44
x | P/E ratio 2025 * |
18.7
x | Employees | 2,510 |
| Yield 2024 * |
0.17% | Yield 2025 * |
1.2% | Free-Float | 59.26% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +5.93% | ||
| 1 week | -4.25% | ||
| Current month | +13.96% | ||
| 1 month | +6.76% | ||
| 3 months | -2.27% | ||
| 6 months | -39.91% | ||
| Current year | -26.36% |
1 week
8.10
9.70
1 month
8.1010.20
Current year
8.1013.00
1 year
8.1023.46
3 years
8.1070.41
5 years
8.1070.41
10 years
8.1070.41
| Managers | Title | Age | Since |
|---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 01/12/01 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 01/19/01 |
Ye Li
CHM | Chairman | 42 | 01/07/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 11/95/11 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 01/96/01 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 01/99/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.24% | 4 M€ | -27.92% | ||
| 0.01% | 117 M€ | +2.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/24/06 | 9.47 | +5.93% | 4 567 000 |
| 03/24/03 | 8.94 | +1.48% | 266,563 |
| 02/24/02 | 8.81 | +6.02% | 794,854 |
| 30/24/30 | 8.31 | -15.98% | 5,757,128 |
| 29/24/29 | 9.89 | +2.17% | 1,157,069 |
Delayed Quote Hong Kong S.E., May 06, 2024 at 11:02 am IST
More quotes
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
Calendar
27/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.39
CNY
Average target price
18.66
CNY
Spread / Average Target
+13.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.69% | 47.9B | |
| +46.90% | 41.42B | |
| -3.46% | 40.7B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +0.17% | 12.15B | |
| +28.07% | 12.14B | |
| -1.24% | 11.99B |
- Stock Market
- Equities
- 603127 Stock
- 6127 Stock